ClinicalTrials.Veeva

Menu

Role of Some Biochemical Indices for Prediction of Acute Kidney Injury in Intensive Care Unit Patients in Upper Egypt

A

Assiut University

Status

Not yet enrolling

Conditions

Acute Kidney Injury

Treatments

Diagnostic Test: biochemical indices

Study type

Observational

Funder types

Other

Identifiers

NCT06791200
prediction of AKI in icu

Details and patient eligibility

About

  1. We will investigate the relation between the triglyceride-glucose index and the development of AKI in ICU.
  2. To detect whether the TGI is a predictor of poor outcome (requirement of renal replacement therapy, or 14-day in-hospital mortality, and length of hospital stay) in ICU.
  3. Compare TGL, Neutrophil-to-lymphocyte ratio, and clinical score (sequential organ failure assessment SOFA score) as predictors of poor outcome in ICU.

Full description

Acute kidney injury (AKI) is a common clinical syndrome with a broad aetiological profile. It complicates about 5% of hospital admissions and 30% of admissions to intensive care units (ICU). During last 20 years has been a significant change in the spectrum of severe AKI such that it is no longer mostly a single organ phenomenon but rather a complex multisystem clinical problem. mortality from AKI, when part of MOF, remains over 50%.

In the past few decades, the understanding of AKI has greatly improved, but early diagnosis remains a great challenge. The performance of traditional kidney function index and serum creatinine is very limited for the early diagnosis of acute kidney injury The triglyceride glucose index (TGI) has been suggested as a useful marker of insulin resistance. Previous studies have shown that TGI is associated with many diseases, but no study has examined the relationship between TGI and Aki .

the primary objective of the present study was to investigate the relationship between TGI and Aki.

Enrollment

100 estimated patients

Sex

All

Ages

16+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • The selected patients will be with the following inclusion criteria:

Patients admitted to ICU within 24 hours

Exclusion criteria

  • We will exclude those with any of the following:

    1. Patients diagnosed more than 24 hours.
    2. Patients with missing data of triglyceride or glucose.
    3. Patients <18years old.
    4. patient with advanced liver disease and chronic kidney disease with or without dialysis

Trial contacts and locations

1

Loading...

Central trial contact

Ehdaa Ahmed Sanosy a Ehdaa Sanosy, Resident in Internal Medicine; Prof. Dr. Lobna Farrag El Toony f El Toony, Professor of Internal Medicine

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems